Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524394 · ClinicalTrials.gov registry record
Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00524394: Clinical Trial study, sponsored by The University of Texas Health Science Center, Houston.
NCT00524394 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00524394 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Infants in the NICU are at high risk for morbidity and mortality from infections of any onset. Diagnosis of these infections is imperfect at best. Patterns of inflammatory and regulatory proteins (cytokines \& chemokines, in addition to antigen detection on antibody secreting cells (ASC's)may provide a more accurate and rapid approach to diagnosis of infections in these high-risk patients.
Primary Outcome
Describe changes in immunological homeostasis that indicate the "normal" function vs. presence of sepsis in newborn infants of various gestational ages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-01 |
Why NCT00524394 stopped before completion
NCT00524394 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00524394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00524394 about?
NCT00524394 is a clinical study titled "Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation". Infants in the NICU are at high risk for morbidity and mortality from infections of any onset. Diagnosis of these infections is imperfect at best. Patterns of inflammatory and regulatory proteins (cytokines \& chemokines, in addition to antigen detection on antibody secreting cells (ASC's)may provid...
What is the current status of trial NCT00524394?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2007-08. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT00524394?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia